(firstQuint)EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients.

 Study's participants are CHF, COPD and Pneumonia patients or patients who are otherwise hospitalized in internal medicine department.

 During the study the patients' breathing patterns, heart rate, restlessness and cough in sleep will be measured by the EarlySense ES 16 device, which is placed in the patients' bed.

 Patients' clinical status are followed.

 The patient's clinical condition is followed and analyzed in comparison to the EarlySense system output in order to determine the capability of the EarlySense system to predict COPD, CHF or Pneumonia deteriorations.

.

 EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients@highlight

Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device.

 Predicting worsening in COPD patients' condition using the above parameters.

